 Reuters India |
Roche's New Diabetes Drug Works Better Than Byetta
Wall Street Journal VX) said Thursday its experimental diabetes drug taspoglutide worked better than a rival drug sold by Eli Lilly & Co. (LLY) in lowering blood sugar, … UPDATE 2-Ipsen ups margin goal, diabetes drug hits test targetReuters Roche diabetes drug beats ByettaFierceBiotech Roche: Taspoglutide Meets Endpoint In Type 2 Diabetes TrialsCapital.gr (press release) Genetic Engineering News (press release) -WELT ONLINE -Pharma Times all 43 news articles » |
Mail this post